These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

164 related items for PubMed ID: 11193881

  • 21. VIP and PACAP enhance the in vivo generation of memory TH2 cells by inhibiting peripheral deletion of antigen-specific effectors.
    Delgado M, Ganea D.
    Arch Physiol Biochem; 2001 Oct; 109(4):372-6. PubMed ID: 11935376
    [Abstract] [Full Text] [Related]

  • 22. Therapeutical approaches of vasoactive intestinal peptide as a pleiotropic immunomodulator.
    Gonzalez-Rey E, Varela N, Chorny A, Delgado M.
    Curr Pharm Des; 2007 Oct; 13(11):1113-39. PubMed ID: 17430175
    [Abstract] [Full Text] [Related]

  • 23. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit chemokine production in activated microglia.
    Delgado M, Jonakait GM, Ganea D.
    Glia; 2002 Aug; 39(2):148-61. PubMed ID: 12112366
    [Abstract] [Full Text] [Related]

  • 24. VIP and PACAP down-regulate CXCL10 (IP-10) and up-regulate CCL22 (MDC) in spleen cells.
    Jiang X, Jing H, Ganea D.
    J Neuroimmunol; 2002 Dec; 133(1-2):81-94. PubMed ID: 12446011
    [Abstract] [Full Text] [Related]

  • 25. VIP and PACAP inhibit activation induced apoptosis in T lymphocytes.
    Delgado M, Ganea D.
    Ann N Y Acad Sci; 2000 Dec; 921():55-67. PubMed ID: 11193880
    [Abstract] [Full Text] [Related]

  • 26. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit expression of Fas ligand in activated T lymphocytes by regulating c-Myc, NF-kappa B, NF-AT, and early growth factors 2/3.
    Delgado M, Ganea D.
    J Immunol; 2001 Jan 15; 166(2):1028-40. PubMed ID: 11145682
    [Abstract] [Full Text] [Related]

  • 27. Inhibition of endotoxin-induced macrophage chemokine production by VIP and PACAP in vitro and in vivo.
    Delgado M, Ganea D.
    Arch Physiol Biochem; 2001 Oct 15; 109(4):377-82. PubMed ID: 11935377
    [Abstract] [Full Text] [Related]

  • 28. VIP and PACAP enhance IL-6 release and mRNA levels in resting peritoneal macrophages: in vitro and in vivo studies.
    Martinez C, Delgado M, Pozo D, Leceta J, Calvo JR, Ganea D, Gomariz RP.
    J Neuroimmunol; 1998 May 15; 85(2):155-67. PubMed ID: 9630164
    [Abstract] [Full Text] [Related]

  • 29. Differential expression of costimulatory molecules B7-1 and B7-2 on microglial cells induced by Th1 and Th2 cells in organotypic brain tissue.
    Wolf SA, Gimsa U, Bechmann I, Nitsch R.
    Glia; 2001 Dec 15; 36(3):414-20. PubMed ID: 11746777
    [Abstract] [Full Text] [Related]

  • 30. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit T cell-mediated cytotoxicity by inhibiting Fas ligand expression.
    Delgado M, Ganea D.
    J Immunol; 2000 Jul 01; 165(1):114-23. PubMed ID: 10861043
    [Abstract] [Full Text] [Related]

  • 31. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit endotoxin-induced TNF-alpha production by macrophages: in vitro and in vivo studies.
    Delgado M, Pozo D, Martinez C, Leceta J, Calvo JR, Ganea D, Gomariz RP.
    J Immunol; 1999 Feb 15; 162(4):2358-67. PubMed ID: 9973516
    [Abstract] [Full Text] [Related]

  • 32. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide-38 inhibit IL-10 production in murine T lymphocytes.
    Martinez C, Delgado M, Gomariz RP, Ganea D.
    J Immunol; 1996 Jun 01; 156(11):4128-36. PubMed ID: 8666779
    [Abstract] [Full Text] [Related]

  • 33. Chronic helminth infection induces alternatively activated macrophages expressing high levels of CCR5 with low interleukin-12 production and Th2-biasing ability.
    Rodríguez-Sosa M, Satoskar AR, Calderón R, Gomez-Garcia L, Saavedra R, Bojalil R, Terrazas LI.
    Infect Immun; 2002 Jul 01; 70(7):3656-64. PubMed ID: 12065507
    [Abstract] [Full Text] [Related]

  • 34. Pituitary adenylate cyclase activating polypeptide (PACAP) and vasoactive intestinal peptide (VIP) stimulate interleukin-6 production through the third subtype of PACAP/VIP receptor in rat bone marrow-derived stromal cells.
    Cai Y, Xin X, Shim GJ, Mokuno Y, Uehara H, Yamada T, Agui T, Matsumoto K.
    Endocrinology; 1997 Jun 01; 138(6):2515-20. PubMed ID: 9165043
    [Abstract] [Full Text] [Related]

  • 35. Pertussis toxin potentiates Th1 and Th2 responses to co-injected antigen: adjuvant action is associated with enhanced regulatory cytokine production and expression of the co-stimulatory molecules B7-1, B7-2 and CD28.
    Ryan M, McCarthy L, Rappuoli R, Mahon BP, Mills KH.
    Int Immunol; 1998 May 01; 10(5):651-62. PubMed ID: 9645613
    [Abstract] [Full Text] [Related]

  • 36. Regulatory effects of vasoactive intestinal peptide on cytokine production in central and peripheral lymphoid organs.
    Ganea D.
    Adv Neuroimmunol; 1996 May 01; 6(1):61-74. PubMed ID: 8790782
    [Abstract] [Full Text] [Related]

  • 37. A cloned frog vasoactive intestinal polypeptide/pituitary adenylate cyclase-activating polypeptide receptor exhibits pharmacological and tissue distribution characteristics of both VPAC1 and VPAC2 receptors in mammals.
    Alexandre D, Anouar Y, Jegou S, Fournier A, Vaudry H.
    Endocrinology; 1999 Mar 01; 140(3):1285-93. PubMed ID: 10067855
    [Abstract] [Full Text] [Related]

  • 38. VIP1 and VIP2 receptors but not PVR1 mediate the effect of VIP/PACAP on cytokine production in T lymphocytes.
    Jiang X, Wang HY, Yu J, Ganea D.
    Ann N Y Acad Sci; 1998 Dec 11; 865():397-407. PubMed ID: 9928038
    [Abstract] [Full Text] [Related]

  • 39. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide modulate endotoxin-induced IL-6 production by murine peritoneal macrophages.
    Martínez C, Delgado M, Pozo D, Leceta J, Calvo JR, Ganea D, Gomariz RP.
    J Leukoc Biol; 1998 May 11; 63(5):591-601. PubMed ID: 9581803
    [Abstract] [Full Text] [Related]

  • 40. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit interleukin-12 transcription by regulating nuclear factor kappaB and Ets activation.
    Delgado M, Ganea D.
    J Biol Chem; 1999 Nov 05; 274(45):31930-40. PubMed ID: 10542221
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.